Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000930413-23-002065
Filing Date
2023-08-31
Accepted
2023-08-31 08:00:18
Documents
10
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 c106868_6k.htm 6-K 18514
2 c106868_ex99-1.htm EX-99.1 457654
3 c106868_ex99-2.htm EX-99.2 236064
4 c106868_ex99-3.htm EX-99.3 119518
5 c106868_ex99-4.htm EX-99.4 8662
6 c106868_ex99-5.htm EX-99.5 118952
7 c106868_ex99-6.htm EX-99.6 121920
8 c106868_ex99-7.htm EX-99.7 8179
9 c106868_ex99-8.htm EX-99.8 38843
10 GRAPHIC x2_c106868x101x1.jpg GRAPHIC 8175
  Complete submission text file 0000930413-23-002065.txt   1140804
Mailing Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273
Business Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273 354 422-4500
Alvotech (Filer) CIK: 0001898416 (see all company filings)

EIN.: 981629342 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41421 | Film No.: 231227033
SIC: 2836 Biological Products, (No Diagnostic Substances)